The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.
The best Bull and Bear pitches based on recency and number of recommendations.
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about CRY.
Recs
inov8d
(32.80)
Submitted: 3/16/2020 11:58:47 PM :
Start Price:
$18.00
NYSE:CRY Score:
+87.33
flat revenue, low & unstable earnings. high debt. short.
Recs
mindbender
(< 20)
Submitted: 9/10/2014 4:55:25 PM :
Start Price:
$9.82
NYSE:CRY Score:
-47.01
New developments in wound closure. Strong balance sheet with room to increase dividend.
Recs
InvestmentMAGE
(< 20)
Submitted: 3/22/2014 3:03:40 PM :
Start Price:
$9.50
NYSE:CRY Score:
-56.32
Ben Graham screen
Find the members with the highest scoring picks in CRY.
See what the Wall Street professionals think, according to their public statements and filings.
